• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Are vaccines against COVID-19 tailored to the most vulnerable people?针对新冠病毒的疫苗是为最脆弱人群量身定制的吗？
Vaccine. 2021 Apr 22;39(17):2325-2327. doi: 10.1016/j.vaccine.2021.03.066. Epub 2021 Mar 22.
2
Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist.考虑到脆弱性在 SARS-CoV-2 疫苗开发中的作用：老年病医生如何提供帮助。
Clin Interv Aging. 2021 Apr 28;16:731-738. doi: 10.2147/CIA.S295522. eCollection 2021.
3
COVID-19 vaccination and frailty in older adults.老年人中的新冠病毒疫苗接种与虚弱状况
Arch Gerontol Geriatr. 2021 Sep-Oct;96:104487. doi: 10.1016/j.archger.2021.104487. Epub 2021 Jul 14.
4
Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents. frail 养老院居民接种 BNT162b2 mRNA 疫苗 6 个月后的安全性、有效性和免疫原性。
Drugs Aging. 2022 Jul;39(7):587-595. doi: 10.1007/s40266-022-00959-6. Epub 2022 Jul 7.
5
Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study.BNT162b2 疫苗在体弱或残疾的疗养院居民中的免疫原性：COVID-A 研究。
J Am Geriatr Soc. 2021 Jun;69(6):1441-1447. doi: 10.1111/jgs.17153. Epub 2021 Apr 2.
6
Frailty in the face of COVID-19.面对新冠疫情时的虚弱状态。
Age Ageing. 2020 Jul 1;49(4):499-500. doi: 10.1093/ageing/afaa095.
7
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study.监测意大利长期护理中心的 COVID-19 疫苗使用情况：GeroCovid VAX 研究。
Vaccine. 2022 Apr 1;40(15):2324-2330. doi: 10.1016/j.vaccine.2022.02.064. Epub 2022 Feb 22.
8
Impact of Frailty on Dietary Habits among Community-Dwelling Older Persons during the COVID-19 Pandemic in Japan.日本新冠疫情期间衰弱对社区居住老年人饮食习惯的影响。
J Frailty Aging. 2022;11(1):109-114. doi: 10.14283/jfa.2021.45.
9
The frailty and mortality relationship in patients with COVID-19.新型冠状病毒肺炎患者的虚弱与死亡率关系
Eur Geriatr Med. 2021 Feb;12(1):213-214. doi: 10.1007/s41999-020-00391-2. Epub 2021 Jan 3.
10
Changes in psychological distress before and during the COVID-19 pandemic among older adults: the contribution of frailty transitions and multimorbidity.新冠疫情之前及期间老年人心理困扰的变化：虚弱转变和多种疾病的影响
Age Ageing. 2021 Jun 28;50(4):1011-1018. doi: 10.1093/ageing/afab061.

引用本文的文献

1
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales.英格兰和威尔士全国队列中孕妇对新冠病毒病（COVID-19）和流感疫苗的接种情况
NPJ Vaccines. 2024 Aug 14;9(1):147. doi: 10.1038/s41541-024-00934-9.
2
Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study.长期护理机构居民中 SARS-CoV-2 疫苗接种的疗效和安全性的性别差异：来自 GeroCovid Vax 研究的见解。
Intern Emerg Med. 2023 Aug;18(5):1337-1347. doi: 10.1007/s11739-023-03283-y. Epub 2023 Apr 29.
3
Multimorbidity and Its Effect on Self-Reported Adverse Effects Following COVID-19 Vaccination.多重疾病及其对新冠病毒疫苗接种后自我报告的不良反应的影响。
Cureus. 2022 Dec 30;14(12):e33139. doi: 10.7759/cureus.33139. eCollection 2022 Dec.
4
Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia.伴有合并症患者接种两剂 COVID-19 疫苗后的副作用监测：来自沙特阿拉伯的亚组分析。
Medicina (Kaunas). 2022 Dec 6;58(12):1799. doi: 10.3390/medicina58121799.
5
Association between vaccination and preventive routines on COVID-19-related mortality in nursing home facilities: a population-based systematic retrospective chart review.养老机构中 COVID-19 相关死亡率与疫苗接种和预防措施的关系：基于人群的系统回顾病历分析。
Prim Health Care Res Dev. 2022 Nov 18;23:e75. doi: 10.1017/S1463423622000640.
6
Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway.挪威老年人群中 COVID-19 mRNA 疫苗在全因死亡率方面的短期安全性。
Vaccine. 2023 Jan 9;41(2):323-332. doi: 10.1016/j.vaccine.2022.10.085. Epub 2022 Nov 7.
7
COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making.老年人的 COVID-19 疫苗：疫苗开发和政策制定中的挑战。
Clin Geriatr Med. 2022 Aug;38(3):605-620. doi: 10.1016/j.cger.2022.03.006. Epub 2022 Mar 21.
8
COVID-19 Vaccines: Current and Future Perspectives.新冠疫苗：现状与未来展望
Vaccines (Basel). 2022 Apr 13;10(4):608. doi: 10.3390/vaccines10040608.
9
COVID-19 Vaccination for Frail Older Adults in Singapore - Rapid Evidence Summary and Delphi Consensus Statements.新加坡体弱老年人的 COVID-19 疫苗接种-快速证据摘要和德尔菲共识声明。
J Frailty Aging. 2022;11(2):236-241. doi: 10.14283/jfa.2022.12.
10
Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong.香港与新冠病毒疫苗相关的多种合并症和特殊关注不良事件。
Nat Commun. 2022 Jan 20;13(1):411. doi: 10.1038/s41467-022-28068-3.

本文引用的文献

1
Assessing the impact of COVID-19 on the health of geriatric patients: The European GeroCovid Observational Study.评估 COVID-19 对老年患者健康的影响：欧洲老年 COVID 观察研究。
Eur J Intern Med. 2021 May;87:29-35. doi: 10.1016/j.ejim.2021.01.017. Epub 2021 Jan 31.
2
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
3
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.在年轻和老年成年人中进行的一次单盲、随机、对照、2/3 期试验中，观察 ChAdOx1 nCoV-19 疫苗在初免-加强免疫方案中的安全性和免疫原性（COV002）。
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
6
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
7
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.《 老年人中新型冠状病毒 mRNA-1273 疫苗的安全性和免疫原性》
N Engl J Med. 2020 Dec 17;383(25):2427-2438. doi: 10.1056/NEJMoa2028436. Epub 2020 Sep 29.
8
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study.衰弱对 COVID-19 患者生存的影响（COPE）：一项多中心、欧洲、观察性队列研究。
Lancet Public Health. 2020 Aug;5(8):e444-e451. doi: 10.1016/S2468-2667(20)30146-8. Epub 2020 Jun 30.
9
Immunosenescence and human vaccine immune responses.免疫衰老与人类疫苗免疫反应。
Immun Ageing. 2019 Sep 13;16:25. doi: 10.1186/s12979-019-0164-9. eCollection 2019.
10
Fluzone® High-Dose Influenza Vaccine.流感全病毒裂解疫苗高剂量剂型
Expert Rev Vaccines. 2016 Dec;15(12):1495-1505. doi: 10.1080/14760584.2016.1254044. Epub 2016 Nov 14.

Are vaccines against COVID-19 tailored to the most vulnerable people?

作者信息

Antonelli Incalzi Raffaele, Trevisan Caterina, Del Signore Susanna, Volpato Stefano, Fumagalli Stefano, Monzani Fabio, Bellelli Giuseppe, Gareri Pietro, Mossello Enrico, Malara Alba, Coin Alessandra, Zia Gianluca, Ranhoff Anette Hylen

机构信息

Unit of Geriatrics, Department of Medicine, Campus Bio-Medico University and Teaching Hospital, Rome, Italy.

Geriatrics Division, Department of Medicine (DIMED), University of Padua, Italy.

出版信息

Vaccine. 2021 Apr 22;39(17):2325-2327. doi: 10.1016/j.vaccine.2021.03.066. Epub 2021 Mar 22.

DOI:10.1016/j.vaccine.2021.03.066
PMID:33810907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7983447/
Abstract
摘要